ISL1 and coronary artery disorder: So far, there are few ISL1 mutations reported in human CHD cases, which probably can be explained by early embryonic lethality of Isl1 inactivation and no gross phenotype of heterozygous Isl1 mutants as shown in mouse model (Pfaff et al., 1996; Cai et al., 2003).